Daxen has built an in-house production line to process Ganoderma products combining advanced technology with Dr. Lim’s medical theory of Ganoderma. DXN Pharmaceutical Sdn. Bhd is an integrated factory of 28, 000 square feet. This facility allows the quality maintenance and assurance under Daxen’s strict supervision of the entire production procedure from cultivation, processing and packaging to market. DXN Pharmaceutical also ensures high production capacity to meet Daxen’s ever-growing demand for products as its membership growth accelerates worldwide.
Daxen’s successful expansion globally is recognized internationally by its vast growth of members worldwide and our amplification of footprint in key strategic locations. To provide better services and to support Daxen members in North America to develop local markets, Daxen USA launched in March 2002 and Daxen Canada in January 2003. In order to provide complete service coverage to North America, Daxen Mexico is in its final completion stage, projected to be ready in 2005. Also, Daxen Inc. proudly presents another milestone achievement to our members. Effective from September 30, 2003: Daxen Inc. is now DXN Holdings Bhd., a KLSE-listed company in Malaysia!